JEAN JACQUES BIENAIME Insider Trading
Get free email notifications about insider trading for JEAN JACQUES BIENAIME.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JEAN JACQUES BIENAIME. JEAN JACQUES BIENAIME is a Director in INCYTE CORP ($INCY) and an Chief Executive Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN) and a Director in VITAL THERAPIES INC ($VTL).
Companies in which JEAN JACQUES BIENAIME is an Insider
BIOMARIN PHARMACEUTICAL INC
Trading Symbol: BMRNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JEAN JACQUES BIENAIME: Chief Executive Officer
Holdings: 304,839 shares
Current Value: $27,103,235
Latest Transaction: Jun 23 2021
$BMRN Market Capitalization: $15.63B
$BMRN Previous Close: $88.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IMMUNIC, INC.
Trading Symbol: VTLIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JEAN JACQUES BIENAIME: Director
Holdings: 18,500 shares
Current Value: $86,025
Latest Transaction: Sep 24 2018
$VTL Market Capitalization: $153.84M
$VTL Previous Close: $4.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INCYTE CORP
Trading Symbol: INCYIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of JEAN JACQUES BIENAIME: Director
Holdings: 8,921 shares
Current Value: $1,054,284
Latest Transaction: Jan 05 2021
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of JEAN JACQUES BIENAIME
Sentiment: All, BMRN, VTL, INCY
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 23 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 37.46 | 1,000 | 37,460 | 138,000 | |
Jun 23 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 37.46 | 1,000 | 37,460 | 304,839 | 303.8 K to 304.8 K (+0.33 %) |
May 12 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 8,513 | 225,509 | 0 | |
May 12 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 77.29 | 8,513 | 657,970 | 303,839 | 312.4 K to 303.8 K (-2.73 %) |
May 12 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 8,513 | 225,509 | 312,352 | 303.8 K to 312.4 K (+2.80 %) |
May 10 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 25,000 | 662,250 | 8,513 | |
May 10 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 25,000 | 662,250 | 33,513 |